Company Description

Cizzle Bio is driving a new era in cancer diagnostics, empowering patients and physicians with early-detection biomarker blood tests for cancer developed by the world’s leading experts. Their flagship test, the CIZ1B Biomarker Blood Test for Lung Cancer, is a leading-edge breakthrough in minimally invasive, highly accurate early detection for the world’s deadliest cancer.